Bayesian Capital Management, LP - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bayesian Capital Management, LP ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$641,413
-4.8%
39,716
+254.6%
0.07%
-12.0%
Q1 2023$673,568
+99.9%
11,200
+130.9%
0.08%
+31.7%
Q2 2022$337,000
-12.0%
4,850
+67.6%
0.06%
-28.4%
Q1 2021$383,000
-10.1%
2,894
+17.7%
0.09%
-20.7%
Q4 2020$426,000
+86.8%
2,459
-8.9%
0.11%
+184.6%
Q4 2019$228,000
+185.0%
2,700
-73.5%
0.04%
+95.0%
Q4 2016$80,00010,1890.02%
Other shareholders
NOVOCURE LTD shareholders Q3 2023
NameSharesValueWeighting ↓
StepStone Group LP 115,479$7,302,00011.05%
HARTLINE INVESTMENT CORP/ 335,585$21,219,0005.07%
Darsana Capital Partners LP 1,500,000$94,845,0003.08%
Rhenman & Partners Asset Management AB 365,899$23,136,0002.55%
COURAGE CAPITAL MANAGEMENT LLC 20,000$1,265,0002.15%
Taylor Frigon Capital Management LLC 46,599$2,946,0002.04%
Granite Investment Partners, LLC 411,659$26,029,0001.40%
Nicholas Investment Partners, LP 146,106$9,238,0000.85%
Baillie Gifford 8,829,449$558,287,0000.59%
Cortina Asset Management, LLC 141,352$8,938,0000.55%
View complete list of NOVOCURE LTD shareholders